IL37 and renal carcinoma: Recent studies have reported the antitumor role of IL-37 in various tumor types, such as lung cancer 13,27, colon cancer 28, hepatocellular carcinoma 10,11, renal cancer 29, breast cancer 30, cervical cancer 31 and gallbladder cancer 32 cases.